ArticleFrontiers in immunology2026
Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.
Qian Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.